The physical assessment showed no notable abnormalities, and tumor markers, including alpha-fetoprotein (AFP), carcinoembryonic antigen, carbohydrate antigen 19-9, total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), fPSA/tPSA (f/t), squamous cell carcinoma associated antigen, cytokeratin 19 fragments (CYFRA21-1), neuron-specific enolase, carbohydrate antigen 72-4, pro-gastrin-releasing peptide, and carbohydrate antigen 24-2, were within normal range. The gene discussed is KLK3; the disease is neoplasm.